Abstract
BackgroundTreatment effect of tumor necrosis factor α (TNFα) inhibitors is still low in patients with rheumatoid arthritis (RA), around 50%-70%. Thus more drugs by targeting proliferation of synovial fibroblasts (FLS)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have